Objective To investigate the clinical effect of mitomycin C (MMC) on the corneal endothelium and corneal posterior surface after laser subepithelial keratomileusis (LASEK). Methods In a continuity prospective double-blind study, 0.02% MMC was used topically for 20 seconds in 33 eyes of 33 patients who had undergone LASEK after excimer laser ablation in the Fudan EENT Hospital. The other eye of these patients without MMC treatment was used as the control. Three and 6 months after surgery, the changes in the curve and elevation of the corneal posterior surface, and the density and variation coefficient of corneal endothelial cells were observed to evaluate the MMC toxicity. Data were analyzed using a paired t test. Results In the MMC-treated eyes, 3 and 6 months after the operation, the average corneal endothelium cell density was 3353.3±290.3 cells/mm2 and 3407.6±298.4 cells/mm2; the variation coefficient was 13.36%±6.29% and 13.48±4.34%. In the control eyes 3 and 6 months after the operation, the average corneal endothelium cell density was 3258.7±284.6 cells/mm2 and 3339.2±213.4 cells/mm2; the variation coefficient was 14.52%±7.85% and 14.06%±6.50%. The changes in the elevation and curve of the corneal posterior surface in the MMC treated eyes were -0.67±2.26 μm and -0.52±2.67 μm and 0.01±0.20 D and 0.01±0.21 D, 3 and 6 months after the operation. The changes in the control eyes were -0.85±2.31 μm and -0.15±3.00 μm and -0.01±0.22 D and 0.05±0.17 D at the respective time points after the operation. There were no significant differences in the above parameters either between preoperative or postoperative data or between these two groups. Conclusion The study showed that the application of 0.02% mitomycin C in LASEK is safe.
陈昕纬,陈昕阳,戚晓圆,周浩,褚仁远,周行涛,戴锦晖. 准分子激光上皮下角膜磨镶术中应用丝裂霉素C对角膜内皮及后表面的影响[J]. 中华眼视光学与视觉科学杂志, 2013, 15(7): 428-431.
CHEN Xin-wei,CHEN Xin-yang,QI Xiao-yuan,ZHOU Hao,CHU Ren-yuan,ZHOU Xing-tao,DAI Jin-hui. The effect of mitomycin C on the corneal endothelium and corneal posterior surface after laser subepithelial keratomileusis. Chinese Journal of Optometry Ophthalmology and Visual Science, 2013, 15(7): 428-431. DOI: 10.3760/cma.j.issn.1674-845X.2013.07.011
Qazi MA, Sanderson JP, Mahmoud AM, et al. Postoperative changes in intraocular pressure and corneal biomechanical metrics Laser in situ keratomileusis versus laser-assisted subepithelial keratectomy. J Cataract Refract Surg,2009,35:1774-1788.
[2]
Rajan MS, Watters W, Patmore A, et al. In vitro human corneal model to investigate stromal epithelial interactions following refractive surgery. J Cataract Refract Surg,2005,31:1789-1801.
[3]
Gambato C, Ghirlando A, Moretto E, et al. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology,2005,112:208-218,219.
[4]
Tomasz M. Mitomycin C: small, fast and deadly (but very selective). Chem Biol,1995,2:575-579.
[5]
Torres RM, Merayo-Lloves J, Daya SM, et al. Presence of mitomycin-C in the anterior chamber after photorefractive keratectomy. J Cataract Refract Surg,2006,32:67-71.
[6]
Talamo JH, Gollamudi S, Green WR, et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol,1991,109:1141-1146.
[7]
Kim TI, Tchah H, Lee SA, et al. Apoptosis in keratocytes caused by mitomycin C. Invest Ophthalmol Vis Sci,2003,44:1912-1917.
[8]
Kim TI, Pak J H, Lee SY, et al. Mitomycin C-induced reduction of keratocytes and fibroblasts after photorefractive keratectomy. Invest Ophthalmol Vis Sci,2004,45:2978-2984.
[9]
Netto MV, Mohan RR, Sinha S, et al. Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. J Refract Surg,2006,22:562-574.
[10]
de Benito-Llopis L, Canadas P, Drake P, et al. Keratocyte density 3 months, 15 months, and 3 years after corneal surface ablation with mitomycin C. Am J Ophthalmol,2012,153:17-23.
[11]
Zare M, Feizi S, Azimzadeh A, et al. Effect of photorefractive keratectomy with mitomycin-C on corneal biomechanical features. Curr Eye Res,2012,37:457-462.
[12]
Morales AJ, Zadok D, Mora-Retana R, et al. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol,2006,142:400-404.
[13]
Nassiri N, Farahangiz S, Rahnavardi M, et al. Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial. J Cataract Refract Surg,2008,34:902-908.
Goldsberry DH, Epstein RJ, Majmudar PA, et al. Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg,2007,23:724-727.
[16]
Zhao LQ, Wei RL, Ma XY, et al. Effect of intraoperative mitomycin-C on healthy corneal endothelium after laser-assisted subepithelial keratectomy. J Cataract Refract Surg,2008,34:1715-1719.